Advertisement

Immunodeficiency of Tumor Necrosis Factor and Lymphotoxin-α Double-Deficient Mice

  • Hans-Pietro Eugster
  • Matthias Müller
  • Michel Le Hir
  • Bernhard Ryffel
Part of the Contemporary Immunology book series (CONTIM)

Abstract

Tumor necrosis factor (TNF) is a iproinflammatory cytokine involved in host defense and pathogenesis of various diseases (1,2). Soluble trimeric TNF ligands bind to TNF receptor 1 (TNFR1) and TNFR2, leading to receptor homotrimer formation (3) and consecutive triggering of various biological responses such as proliferation, cytotoxicity and apoptosis in target cells. Lyrnphotoxin-α (LTα), which like TNF belongs to the family of TNF-like ligands (4), can bind to the same receptors as TNF. Consequently, administration of TNF and LTα leads to similar biological responses in vivo and in vitro. In mice, TNF is mainly expressed in macrophages and T-cells, whereas LTα expression is confined to T- and B-cells. ‘The redundancy in receptor binding and the overlapping expression pattern of TNF and LTα renders a clearcut dissection of their function rather difficult. Therefore, the importance of both ligands to TNF receptor-mediated effects tends to be obscured in single gene knockout mice, because the loss of one ligand may be compensated by the remaining one. Since both genes are very closely linked and map within the major histo compatibility complex (MHC), single mutations cannot be crossed together. Rather, mice deficient for both ligands have to be generated by simultaneous targeting of both genes. Prominent functions of TNF include central roles in endotoxic shock, host defence, and tumor—or parasite—induced cachexia. In addition TNF plays an important, yet undefined role in the pathogenesis of autoimmune diseases (5–9). LTα deficiency has been shown to lead to aberrant development of the spleen and absence of lymph nodes (LNs) (10–11). Recently a third ligand, LTβ, was cloned and characterized as present on the cell surface as a LTα/2LTβ heterotrimer, able to bind to the newly described LTβ specific receptor (12–14).

Keywords

Tumor Necrosis Factor Mutant Mouse Listeria Monocytogenes Vesicular Stomatitis Virus Endotoxic Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aggarwal, B. B. and Vilcek J. (eds.) (1992) Tumor Necrosis Factor, Structure, Function, and Mechanism of Action. Dekker, New York.Google Scholar
  2. 2.
    Beutler, B. (ed.) (1992) Tumour Necrosis Factor: The Molecules and Their Emerging Role In Medicine. Raven, New York.Google Scholar
  3. 3.
    Tartaglia, L. A., Pennica, D., and Goeddel, D. V. (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268, 18,542–18, 548.Google Scholar
  4. 4.
    Beutler, B. and van Huffel, C. (1994) Unraveling function in the TNF ligand and receptor families. Science 264, 667, 668.Google Scholar
  5. 5.
    Guerder, S., Picarella, D. E., Linsley, P. S., and Flavell, R. A. (1994) Costimulator B7–1 confers antigen-presenting-cell function to parenchimal tissue and in conjugation with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 5138–5142.PubMedCrossRefGoogle Scholar
  6. 6.
    Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., and Acha-Orbea, H. (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 87, 968–972.PubMedCrossRefGoogle Scholar
  7. 7.
    Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., and Flavell, R. A. (1992) Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Sci. Acad. USA 89, 10,036–10, 040.Google Scholar
  8. 8.
    Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., and Flavell, R. A. (1993) Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNFalpha and TNF-beta transgenic mice. J. Immunol. 150, 4136–4150.PubMedGoogle Scholar
  9. 9.
    Ruddle, N. H., Bergman, C. M., McGrath, K. M., et al. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193–1200.PubMedCrossRefGoogle Scholar
  10. 10.
    Banks, T. A., Rouse, B. T., Kerley, M. K., et al. (1995) Lymphotoxin-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155, 1685–1693.PubMedGoogle Scholar
  11. 11.
    De Togni, P., Goellner, J., Ruddle, N. H. et al. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703–707.PubMedCrossRefGoogle Scholar
  12. 12.
    Androlewicz, M. J., Browning, J. L., and Ware, C. F. (1992) Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. Biol. Chem. 267, 2542–2547.PubMedGoogle Scholar
  13. 13.
    Baens, M., Chaffanet, M., Cassiman, J. J., van-den-Berghe, H., and Marynen, P. (1993) Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16, 214–218.Google Scholar
  14. 14.
    Crowe, P. D., VanArsdale, T. L., Walter, B. N., Dahms, K. M., and Ware, C. F. (1994) Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. J. Immunol. Methods 168, 79–89.PubMedCrossRefGoogle Scholar
  15. 15.
    Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M., and Schaffner, W. (1994) The transcription factor MTF-1 is essential for basal and heavy metal-induced methallothionein gene expression. EMBO J. 2870–2875.Google Scholar
  16. 16.
    Eugster, H. P., Müller, M., Karrer, U., et al. (1996) Multiple immune abnormalities in tumor necrosis and lymphotoxin a double deficient mice. Int. Immunol. 8, 23–36.PubMedCrossRefGoogle Scholar
  17. 17.
    Tracey, K. J., Fong, Y., Hesse, D. G., et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662–664.PubMedCrossRefGoogle Scholar
  18. 18.
    Pfeffer, K., Matsuyama, T., Kundig, T. M., et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457–467.PubMedCrossRefGoogle Scholar
  19. 19.
    Rothe, J., Lesslauer, W., Lotscher, H., et al. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798–802.CrossRefGoogle Scholar
  20. 20.
    Erickson, S. L., de-Sauvage, F. J., Kikly, K., et al. (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560–563.PubMedCrossRefGoogle Scholar
  21. 21.
    Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., and Wagner, H. (1992) T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175, 91–98.PubMedCrossRefGoogle Scholar
  22. 22.
    de-Kossodo, S., Grau, G. E., Daneva, T., et al. (1992) Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development. J. Exp. Med. 176, 1259–1264.PubMedCrossRefGoogle Scholar
  23. 23.
    Miyawaki, S., Nakamura, Y., Suzuka, H., et al. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24, 429–434.PubMedCrossRefGoogle Scholar
  24. 24.
    Berlin, C., Bargatze, R. F., Campbell, J. J., et al. (1995) Alpha4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80, 413–422.PubMedCrossRefGoogle Scholar
  25. 25.
    Sikorski, E. E., Hallmann, R., Berg, E. L., and Butcher, E. C. (1993) The Peyer’s patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151, 5239–5250.PubMedGoogle Scholar
  26. 26.
    Brandtzaeg, P. (1989) Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146, 13–25.PubMedCrossRefGoogle Scholar
  27. 27.
    Ramsay, A. J., Husband, A. J., Ramshaw, I. A., et al. (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561–563.PubMedCrossRefGoogle Scholar
  28. 28.
    Kopf, M., Baumann, H., Freer, G., et al. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339–342.PubMedCrossRefGoogle Scholar
  29. 29.
    Burks, A., Jr. and Steele, R. W. (1986) Seletive IgA deficiency. Ann. Allergy 57, 3–13.PubMedGoogle Scholar
  30. 30.
    Castigli, E., Alt, F. W., Davidson, L., et al. (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91, 12,135–12, 139.Google Scholar
  31. 31.
    Renshaw, B. R., Fanslow, W. R., Armitage, R. J., et al. (1994) Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889, 1900.Google Scholar
  32. 32.
    Worm, M. and Geha, R. S. (1994) CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int. Immunol. 6, 1883–1890.PubMedCrossRefGoogle Scholar
  33. 33.
    Kohase, M., Henriksen-DeStefano, D., May, L. T., Vilcek, J., and Sehgal, P. B. (1986) Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45, 659–666.PubMedCrossRefGoogle Scholar
  34. 34.
    Leist, T. P. and Zinkernagel, R. M. (1990) Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus. Cytokine 2, 29–34.PubMedCrossRefGoogle Scholar
  35. 35.
    Mestan, J., Digel, W., Mittnacht, S., et al. (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816–819.PubMedCrossRefGoogle Scholar
  36. 36.
    Sambhi, S. K., Kohonen-Corish, M. R., and Ramshaw, I. A. (1991) Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl. Acad. Sci. USA 88, 4025–4029.PubMedCrossRefGoogle Scholar
  37. 37.
    Wong, G. H. and Goeddel, D. V. (1986) Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323, 819–822.PubMedCrossRefGoogle Scholar
  38. 38.
    Kindler, V., Sappino, A. P., Grau, G. E., Piguet, P. F., and Vassalli, P. (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731–740.PubMedCrossRefGoogle Scholar
  39. 39.
    Beckerman, K. P., Rogers, H. W., Corbett, J. A., Schreiber, R. D., McDaniel, M. L., and Unanue, E. R. (1993) Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150, 888–895.Google Scholar
  40. 40.
    Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S., and Kaufmann, S. H. (1993) Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 365, 53–56.PubMedCrossRefGoogle Scholar
  41. 41.
    Kaufmann, S. H. and Ladel, C. H. (1994) Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. Trends Microbiol. 2, 235–242.PubMedCrossRefGoogle Scholar
  42. 42.
    Kagi, D., Ledermann, B., Burki, K., Hengartner, H., and Zinkernagel, R. M. (1994) CD8+ T cell-mediated protection against an intracellular bacterium by perform-dependent cytotoxicity. Eur. J. Immunol. 24, 3068–3072.PubMedCrossRefGoogle Scholar
  43. 43.
    Ladel, C. H., Flesch, I. E., Arnoldi, J., and Kaufmann, S. H. (1994) Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J. Immunol. 153, 3116–3122.PubMedGoogle Scholar
  44. 44.
    Rogers, H. W. and Unanue, E. R. (1993) Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immunol. 61, 5090–5096.Google Scholar
  45. 45.
    Hsieh, C. S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O’Garra, A., and Murphy, K. M. (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages [see comments]. Science 260, 547–549.PubMedCrossRefGoogle Scholar
  46. 46.
    Tripp, C. S., Wolf, S. F., and Unanue, E. R. (1993) Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90, 3725–3729.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Hans-Pietro Eugster
  • Matthias Müller
  • Michel Le Hir
  • Bernhard Ryffel

There are no affiliations available

Personalised recommendations